Volume 2, Issue 6, Page 2 (June 2006)
5 of 37
PREVIEW
FULL TEXT
FULL-TEXT PDF (116 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
SAN DIEGO — Evidence that the investigatory drug CEP-1347 failed to provide neuroprotection to patients with early Parkinson's disease was presented at the annual meeting of the American Academy of Neurology.
PII: S1553-3212(06)71543-6
doi:10.1016/S1553-3212(06)71543-6
© 2006 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.